Guideline on quality aspects included in the product information for vaccines for human use

  • Email
  • Help

Document details

Download document Guideline on quality aspects included in the product information for vaccines for human use
Reference number EMA/CHMP/BWP/133540/2017
Status draft: consultation open
First published 2018-02-01
Last updated 2018-02-01
Consultation start date 2018-02-01
Consultation end date 2018-07-31
Email address for submissions kaidi.koiv@ema.europa.eu

Summary

This guideline describes the information on the quality aspects to be included in the Product Information (PI) of vaccines for human use.